Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 26 (3) , 473-480
- https://doi.org/10.1016/s0278-5846(01)00291-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidolBritish Journal of Clinical Pharmacology, 2001
- Antipsychotic Polypharmacy, Part 1: Therapeutic Option or Dirty Little Secret?The Journal of Clinical Psychiatry, 1999
- Effects of Gender and Age on Plasma Levels of Clozapine and Its MetabolitesThe Journal of Clinical Psychiatry, 1999
- Pharmacokinetic Interactions of Clozapine With Selective Serotonin Reuptake InhibitorsJournal of Clinical Psychopharmacology, 1998
- Evaluation of Treatment-Resistant SchizophreniaSchizophrenia Bulletin, 1997
- The expanding indications for clozapine.Experimental and Clinical Psychopharmacology, 1997
- Clozapine as a treatment tool: only in resistant schizophrenic patients?European Psychiatry, 1997
- N‐desmethylclozapine: a clozapine metabolite that suppresses haemopoiesisBritish Journal of Haematology, 1994
- Relationship Between Clinical Efficacy and Clozapine Concentrations in Plasma in SchizophreniaJournal of Clinical Psychopharmacology, 1993
- The Assay of Clozapine and N-Desmethylclozapine in Human Plasma by High-Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1991